Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 67-74 , January 2008

Recipient NOD2/CARD15 Variants: A Novel Independent Risk Factor for the Development of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation

  • Gerhard C. Hildebrandt

      Affiliations

    • Department of Hematology and Oncology, University of Regensburg Medical School, Regensburg, Germany
    • Corresponding Author InformationCorrespondence and reprint requests: Gerhard C Hildebrandt, Department of Hematology and Oncology, University of Regensburg Medical School, Franz-Josef-Strauß Allee 11, D-93053 Regensburg, Germany; Tel: +49-941-944-5589, Fax: +49-941-944-5511.
    • ,
  • Miguell Granell

      Affiliations

    • Department of Hematology, Faculty of Medicine, University of Barcelona, Barcelona, Spain
    • ,
  • Alvaro Urbano-Ispizua

      Affiliations

    • Department of Hematology, Faculty of Medicine, University of Barcelona, Barcelona, Spain
    • ,
  • Daniel Wolff

      Affiliations

    • Department of Hematology and Oncology, University of Rostock Medical School, Rostock, Germany
    • ,
  • Bernd Hertenstein

      Affiliations

    • Department of Hematology, Hannover Medical University, Hannover, Germany
    • ,
  • Hildegard T. Greinix

      Affiliations

    • Department of Internal Medicine I, Vienna Medical University, Vienna, Austria
    • ,
  • Julia Brenmoehl

      Affiliations

    • Department of Hematology and Oncology, University of Regensburg Medical School, Regensburg, Germany
    • ,
  • Christian Schulz

      Affiliations

    • Department of Pulmonology, University of Regensburg Medical School, Regensburg, Germany
    • ,
  • Anne M. Dickinson

      Affiliations

    • School of Clinical and Laboratory Sciences, University of Newcastle, Newcastle, United Kingdom
    • ,
  • Joachim Hahn

      Affiliations

    • Department of Hematology and Oncology, University of Regensburg Medical School, Regensburg, Germany
    • ,
  • Gerhard Rogler

      Affiliations

    • Department of Gastroenterology, University of Regensburg Medical School, Regensburg, Germany
    • ,
  • Reinhard Andreesen

      Affiliations

    • Department of Hematology and Oncology, University of Regensburg Medical School, Regensburg, Germany
    • ,
  • Ernst Holler

      Affiliations

    • Department of Hematology and Oncology, University of Regensburg Medical School, Regensburg, Germany

Received 29 April 2007 ,Accepted 20 September 2007.

References 

  1. Qu N, de Haan A, Harmsen MC, et al. Specific immune responses against airway epithelial cells in a transgenic mouse trachea transplantation model for obliterative airway disease. Transplantation. 2003;76:1022–1028
  2. Jaramillo A, Fernandez FG, Kuo EY, et al. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant. 2005;9:84–93
  3. Holler E, Rogler G, Herfarth H, et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood. 2004;104:889–894
  4. Granell M, Urbano-Ispizua A, Arostegui JI, et al. Effect of NOD2/CARD15 variants in T-cell–depleted allogeneic stem cell transplantation. Haematologica. 2006;91:1372–1376
  5. Hippenstiel S, Opitz B, Schmeck B, et al. Lung epithelium as a sentinel and effector system in pneumonia–molecular mechanisms of pathogen recognition and signal transduction. Respir Res. 2006;7:97
  6. Parimon T, Madtes DK, Au DH, et al. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med. 2005;172:384–390
  7. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institute of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant. 2006;12:252–266
  8. Hugot JP, Zaccaria I, Cavanaugh J, et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol. 2007;102:1259–1267
  9. Giachino D, van Duist MM, Regazzoni S, et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet. 2004;12:206–212
  10. van der Linde K, Boor PP, Houwing-Duistermaat JJ, et al. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. Eur J Gastroenterol Hepatol. 2007;19:449–459
  11. Santo Tomas LH, Loberiza FR, Klein JP, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest. 2005;128:153–161
  12. Holland HK, Wingard JR, Beschorner WE, et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG. Blood. 1988;72:621–627
  13. Patriarca F, Skert C, Sperotto A, et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant. 2004;33:751–758
  14. Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol. 1998;100:680–687
  15. Dudek AZ, Mahaseth H, DeFor TE, et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant. 2003;9:657–666
  16. Sanchez J, Torres A, Serrano J, et al. Long-term follow-up of immunosuppressive treatment for obstructive airway disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;20:403–408
  17. Chien JW, Martin PJ, Gooley TA, et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003;168:208–214
  18. Beinert T, Dull T, Wolf K, et al. Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res. 1996;1:343–348
  19. Clark JG, Schwartz DA, Flournoy N, et al. Risk factors for air-flow obstruction in recipients of bone marrow transplants. Ann Intern Med. 1987;107:648–656
  20. Clark JG, Crawford SW, Madtes DK, et al. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course. Ann Intern Med. 1989;111:368–376
  21. Duncker C, Dohr D, Harsdorf S, et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single-center study of incidence, risk factors and outcome. Bone Marrow Transplant. 2000;25:1263–1268
  22. Paz HL, Crilley P, Topolsky DL, et al. Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning. Respiration. 1993;60:109–114
  23. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J Biol Chem. 2003;278:5509–5512
  24. Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol. 2002;5:76–80
  25. Berrebi D, Maudinas R, Hugot JP, et al. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut. 2003;52:840–846
  26. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 2003;124:993–1000
  27. Opitz B, Puschel A, Schmeck B, et al. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem. 2004;279:36426–36432
  28. Uehara A, Fujimoto Y, Fukase K, et al. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol. 2007;44(12):3100–3111
  29. Rosenstiel P, Fantini M, Brautigam K, et al. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology. 2003;124:1001–1009
  30. Ross DJ, Cole AM, Yoshioka D, et al. Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2004;78:1222–1224
  31. Nelsestuen GL, Martinez MB, Hertz MI, et al. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics. 2005;5:1705–1713
  32. Xu X, Golden JA, Dolganov G, et al. Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens. J Heart Lung Transplant. 2005;24:1055–1066
  33. Aldhous MC, Nimmo ER, Satsangi J. NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease. Gut. 2003;52:1533–1535
  34. Grimm MC, Pavli P. NOD2 mutations and Crohn's disease: are Paneth cells and their antimicrobial peptides the link?. Gut. 2004;53:1558–1560
  35. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53:1658–1664
  36. Wehkamp J, Schmid M, Fellermann K, et al. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J Leukoc Biol. 2005;77:460–465
  37. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731–734
  38. Voss E, Wehkamp J, Wehkamp K, et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem. 2006;281:2005–2011
  39. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol. 2006;80:500–508
  40. Dosanjh A, Wan B, Ikonen T, et al. Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD). Am J Transplant. 2001;1:321–324
  41. Farivar AS, Mackinnon-Patterson B, McCourtie AS, et al. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha. Exp Mol Pathol. 2005;78:190–197
  42. Naidu B, Krishnadasan B, Whyte RI, et al. Regulatory role of IL-10 in experimental obliterative bronchiolitis in rats. Exp Mol Pathol. 2002;73:164–170
  43. Qu N, de Vos P, Schelfhorst M, et al. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas. J Heart Lung Transplant. 2005;24:882–890
  44. Burman AC, Banovic T, Kuns RD, et al. IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood. 2007;110:1064–1072
  45. Khalid M, Al Saghir A, Saleemi S, et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J. 2005;25:490–493
  46. Chien JW, Zhao LP, Hansen JA, et al. Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation. Blood. 2006;107:2200–2207
  47. Watanabe T, Kitani A, Murray PJ, et al. NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses. Nat Immunol. 2004;5:800–808
  48. Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-κB activation: common genetic etiology with Blau syndrome. Blood. 2005;105:1195–1197
  49. Becker ML, Martin TM, Doyle TM, et al. Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis Rheum. 2007;56:1292–1294

 Dr. Hildebrandt is a Max Eder Scholar of the Deutsche Krebshilfe eV and a Research Scholar of the European Hematology Association.

PII: S1083-8791(07)00464-8

doi: 10.1016/j.bbmt.2007.09.009

Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 67-74 , January 2008

Article Tools

* Image Usage & Resolution